Qing Wang | Neuroscience Discoveries | Best Innovation Award

Published on by Scientist Day

Prof. Qing Wang | Neuroscience Discoveries | Best Innovation Award

Prof. Qing Wang | Southern Medical University | China

Professor Dennis Qing Wang is a distinguished neurologist and neuroscientist recognized for his pioneering research in neurodegenerative diseases, brain imaging, and translational neuroscience. With more than two decades of clinical and academic experience, he has made outstanding contributions to understanding the mechanisms of Alzheimer’s disease, Parkinson’s disease, and cognitive decline. Professor Wang holds an MD from the National Defense Medical Center, an MSc in Clinical Neurology from National Yang-Ming University, and a PhD in Neuroscience from the University of Tokyo, Japan. His multidisciplinary work bridges advanced neuroimaging and molecular neuroscience, fostering early diagnostics and therapeutic innovations that bridge laboratory research and patient care. He has authored 66 peer-reviewed scientific papers, which have collectively received 3,423 citations across 3,040 documents, demonstrating the global impact of his research. With an h-index of 30, his scholarship reflects both depth and sustained influence in the neuroscience community. As Professor of Neurology at Changhua Christian Hospital, he leads research initiatives in neurogenetics, cognitive neuroscience, and neurodegeneration, supervising emerging scientists and clinicians in the field. He has been invited to deliver lectures at leading international conferences and actively contributes to global collaborations in clinical neuroscience.

Profile: Scopus

Featured Publications

Wang, D. Q., et al. (2025). Development and validation of a polysomnography-based nomogram for predicting amnestic mild cognitive impairment in middle-aged and elderly people. Sleep Medicine.

Wang, D. Q., et al. (2025). Vascular depression: A comprehensive exploration of the definition, mechanisms, and clinical challenges.

Wang, D. Q., et al. (2025). Cellular fibronectin exacerbates α-synuclein aggregation via integrin α4β1-mediated PARP1 and SCD elevation. Neurotherapeutics.

Wang, D. Q., et al. (2025). Fibrinogen exacerbates α-synuclein aggregation and mitochondrial dysfunction via α5β3 integrin in Parkinson’s disease.

Wang, D. Q., et al. (2024). Lee Silverman Voice Treatment for dysarthria in patients with Parkinson’s disease: A systematic review and meta-analysis.

Fatemeh Rezaei-Tazangi | Neuroscience Discoveries | Best Research Article Award

Published on by Scientist Day

Dr. Fatemeh Rezaei-Tazangi | Neuroscience Discoveries | Best Research Article Award

Fasa University of Medical Sciences | Iran

Dr. Fatemeh Rezaei-Tazangi, affiliated with Fasa University of Medical Sciences, Iran, is a distinguished researcher in the fields of stem cells, reproductive medicine, cancer biology, and herbal therapeutics. She holds a Ph.D. in Anatomical Sciences from Ahvaz Jundishapur University of Medical Sciences, building on her earlier studies in midwifery and anatomical sciences at Shiraz University of Medical Sciences. Her scholarly contributions are widely recognized, with 59 published documents indexed in Scopus, cited by 568 publications, amounting to 630 citations and an h-index of 13, reflecting the strong impact of her research. Dr. Rezaei-Tazangi’s investigations bridge experimental and translational science, with a special focus on mesenchymal stem cells, oxidative stress, fertility preservation, and the therapeutic promise of natural compounds and nano-based drug formulations. She has provided valuable insights into mechanisms such as ferroptosis, autophagy, epithelial-mesenchymal transition, and stem cell-derived secretomes in relation to cancer and regenerative medicine. Her collaborative research record includes work with over 260 co-authors, highlighting her active engagement with the global scientific community. By combining advanced cellular biology with herbal and nanotechnology-based approaches, she contributes to the development of innovative strategies for reproductive health and oncology. With a growing research impact and a diverse body of work, Dr. Rezaei-Tazangi is an emerging leader in biomedical sciences, committed to advancing healthcare solutions through interdisciplinary and impactful research.

Profile: Scopus | Google Scholar | Orcid

Featured Publications

“Receptor tyrosine kinase inhibitors in cancer”

“Crosstalk between ferroptosis and the epithelial-mesenchymal transition: Implications for inflammation and cancer therapy”

“Cancer stem cells in colorectal cancer: Signaling pathways involved in stemness and therapy resistance”

“The emerging role of regulatory cell-based therapy in autoimmune disease”

“Nano-scale delivery systems for siRNA delivery in cancer therapy: New era of gene therapy empowered by nanotechnology”

“Taurine effects on Bisphenol A-induced oxidative stress in the mouse testicular mitochondria and sperm motility”

“Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response”

“The therapeutic potential of common herbal and nano-based herbal formulations against ovarian cancer: New insight into the current evidence”

“Tumor-derived exosomal non-coding RNAs as diagnostic biomarkers in cancer”

“Quercetin and Osteoarthritis: A Mechanistic Review on the Present Documents”

“The endocannabinoid system, a new gatekeeper in the pharmacology of human hepatocellular carcinoma”

“A review of methods for preserving male fertility”

“Can mesenchymal stem cells derived from adipose tissue and their conditioned medium improve ovarian functions? A mini-review”

“Effects of Wharton’s jelly mesenchymal stem cells-derived secretome on colon carcinoma HT-29 cells”